Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 10, 2010
New structure, leadership team and targeted portfolio changes will focus on sales excellence and cost effectiveness
-
Feb 10, 2010
"We delivered a quarter in line with expectations," said Ray Elliott, President and CEO
-
Feb 1, 2010
Settles three patent disputes with Johnson & Johnson (J&J) that date back to 2003
-
Jan 20, 2010
The patents relate to coatings (drug and polymer) for drug-eluting stents
-
Jan 19, 2010
Boston Scientific will webcast its February 11 conference call with financial results and business highlights for Q4 and FY 2009. Learn how to tune in.
-
Jan 14, 2010
Multi-center, prospective study plans to enroll 187 patients at 11 centers worldwide over the next 18 months
-
Jan 8, 2010
Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms
-
Jan 5, 2010
A webcast of the January 12 session will be available. Learn how to tune in live or watch the replay
-
Jan 5, 2010
MAPS clinical trial studying the coiling of intracranial aneurysms reaches its goal of 630 patients, enrolled at 47 hospitals in 11 countries
-
Jan 4, 2010
Company to contribute data to industry-sponsored Dual Antiplatelet Therapy (DAPT) Study